AMSBIO has expanded its wide and varied catalogue of primary and progenitor cell types and media with a new range of human endothelial progenitor cells (EPC).

Human endothelial progenitor cells are a primitive cell type. They are bone marrow derived cells with properties similar to embryonic angioblasts. Progenitor cells migrate into the blood stream and are able to differentiate into a variety of mature vascular endothelial cell types. EPC play an important role in both angiogenesis and vasculogenesis. Compared to specific mature types of endothelial cells such as HMVECs and HUVECs, human EPC are more suitable for cell-based screening of anti-cancer drugs. Endothelial progenitor cells also have an impact on aging and smoking-related diseases, thereby offering beneficial research and drug discovery use in these areas.

AMSBIO offers various specific sub-types of human EPC including vein, microvascular and aortic. The gene expression pattern of AMSBIO endothelial progenitor cells is more similar...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?